Re: CV and mad panic behaviour
Reply #2329 –
I’m not sure that I would like to see public health decisions based on what’s happening in South Africa. The study that found poor efficacy of the Astrazeneca vaccine looked at 1,000 31 year old men and it hasn’t been published or peer reviewed.
Of considerable concern is the SA Auditor-General’s report that found the SA COVID-19 related procurement is marred by opacity, corruption and mismanagement on a wide scale.
Meanwhile, “A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country.”
Ireland has temporarily suspended use of AstraZeneca’s vaccine “out of an abundance of caution”. There’s nothing wrong with an abundance of caution except when it flies in the face of the evidence and has the potential to place folk at greater risk. Fortunately, apart from the need to get our economy back to near normal, we don’t have the same urgency and can afford to be cautious. However, our Therapeutic Goods Administration has received no reports of blood clots following use of the AstraZeneca vaccine in Australia. The TGA states that “extensive international experience does not indicate an increased risk of blood clots associated with the vaccine. Blood clots can occur naturally and are not uncommon.”